for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

GSK ties up with iTeos to develop cancer treatment

June 14 (Reuters) - GlaxoSmithKline Plc and iTeos Therapeutics will develop and commercialize iTeos’ potential treatment for patients with cancer, the companies said on Monday.

iTeos will receive a $625 million upfront payment. (Reporting by Vishwadha Chander in Bengaluru; Editing by Devika Syamnath)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up